• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

livongohealth

Livongo share prices double after upsized $356m IPO

July 25, 2019 By Brad Perriello

Livongo

Investors added nearly 50% to the share price for Livongo Health (NSDQ:LVGO) today after it raised $355 million with its initial public offering after a last-minute upsizing. The Mountain View, Calif.-based company, which developed a digital health platform to manage chronic diseases, said earlier this week that it planned to float 10.7 million shares at $24 […]

Filed Under: Diabetes, Featured, Funding Roundup, Initial Public Offering (IPO), mHealth (Mobile Health), Wall Street Beat Tagged With: livongohealth

Livongo boosts IPO to $268m midpoint

July 23, 2019 By Brad Perriello

Livongo

Livongo Health yesterday boosted the range on its pending initial public offering, saying the flotation would now fetch nearly $268 million at the midpoint. The Mountain View, Calif.-based company developed a digital health platform to manage chronic diseases, selecting diabetes as its first target. After a series of upsizing announcements, Livongo yesterday said it plans […]

Filed Under: Diabetes, Featured, Funding Roundup, Wall Street Beat Tagged With: livongohealth

Livongo Health files for $100m IPO

July 1, 2019 By Brad Perriello

Livongo

Livongo Health last week filed for an initial public offering worth $100 million for the digital health platform it developed to treat chronic diseases. The Mountain View, Calif.-based company’s initial focus on diabetes involves a smart, cellular-connected glucose meter, automatically-delivered testing materials, real-time coaching and full-time monitoring. The system personalizes messages based on each glucose […]

Filed Under: Diabetes, Featured, Funding Roundup, Initial Public Offering (IPO), mHealth (Mobile Health), Wall Street Beat Tagged With: livongohealth

Livongo adds compatibility with Abbott’s FreeStyle Libre Pro

September 5, 2018 By Fink Densford

Livongo, Abbott

Livongo Health said today it will integrate continuous glucose data from Abbott‘s (NYSE:ABT) FreeStyle Libre Pro system into its Livongo for Diabetes system, touting it as the first such system to integrate data from Abbott’s FreeStyle Libre Pro. With the integration, users of the FreeStyle Libre Pro will be able to see a visual snapshot of […]

Filed Under: Business/Financial News, Diabetes, Featured Tagged With: abbott, livongohealth

Livongo Health acquires weight-management, disease-prevention dev Retrofit

April 18, 2018 By Fink Densford

Livongo, Retrofit

Livongo Health said yesterday it acquired weight-management and disease-prevention program developer Retrofit for an undisclosed amount. With the acquisition, Mountain View, Calif.-based Livongo Health said it will make Retrofit’s Diabetes Prevention program available as Livongo DPP, powered by Retrofit. Livongo said the acquisition acts as a compliment to its Livongo for Diabetes and Livongo for Hypertension […]

Filed Under: Diabetes, Featured, Technology Tagged With: livongohealth, retrofit

Livongo raises $105m for digital diabetes management platform

April 12, 2018 By Sarah Faulkner

Livongo

Livongo Health closed a $105 million round led by a group of investors including General Catalyst, Merck Global Health Innovation Fund and Echo Health Ventures. The Mountain View, Calif.-based company has developed Livongo for Diabetes – a collection of connected devices that enable people with diabetes to interact with a virtual care team. “We are particularly […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Funding Roundup, Technology Tagged With: livongohealth

Livongo buys diabetes management company Diabeto

September 14, 2017 By Sarah Faulkner

Livongo, Diabeto

Livongo Health said yesterday that it bought digital diabetes management company, Diabeto, for an undisclosed amount. Diabeto sells a connectivity technology called Birdie that plugs into more than 40 different glucose meters, connecting them to Diabeto’s mobile apps and to Livongo’s newly-released apps. “We’ve heard from the market that, in addition to a comprehensive solution […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Mergers & Acquisitions, Pharmaceuticals, Wall Street Beat Tagged With: diabeto, livongohealth

Livongo, Glytec ink deal for electronic diabetes management solution

April 18, 2017 By Sarah Faulkner

Glytec logo, Livongo Health logo

Digital Health company Livongo Health said today that it is partnering with Glytec to develop a diabetes management solution that includes insulin titration. The companies plan to expand Glytec’s eGlycemic Management System to improve health outcomes in patients with diabetes. Glytec touted that its suite of FDA-cleared dosing algorithms for IV, subcutaneous and pediatric insulin […]

Filed Under: Diabetes, Featured, Patient Monitoring, Pharmaceuticals, Wall Street Beat Tagged With: Glytec, livongohealth

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS